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ABSTRACT: Type 2 diabetes (T2D) adversely affects many tissues, and the greater incidence of discogenic low back pain among
diabetic patients suggests that the intervertebral disc is affected too. Using a rat model of polygenic obese T2D, we demonstrate that
diabetes compromises several aspects of disc composition, matrix homeostasis, and biomechanical behavior. Coccygeal motion
segments were harvested from 6-month-old lean Sprague-Dawley rats, obese Sprague-Dawley rats, and diabetic obese UCD-T2DM
rats (diabetic for 69 7 days). Findings indicated that diabetes but not obesity reduced disc glycosaminoglycan and water contents,
and these degenerative changes correlated with increased vertebral endplate thickness and decreased endplate porosity, and with
higher levels of the advanced glycation end-product (AGE) pentosidine. Consistent with their diminished glycosaminoglycan and
water contents and their higher AGE levels, discs from diabetic rats were stiffer and exhibited less creep when compressed. At the
matrix level, elevated expression of hypoxia-inducible genes and catabolic markers in the discs from diabetic rats coincided with
increased oxidative stress and greater interactions between AGEs and one of their receptors (RAGE). Taken together, these findings
indicate that endplate sclerosis, increased oxidative stress, and AGE/RAGE-mediated interactions could be important factors for
explaining the greater incidence of disc pathology in T2D. ß 2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
J Orthop Res 9999:1–9, 2015.9999:1–9, 2015.9999:1–9, 2015.
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Low back pain (LBP) is among the leading causes of
disability and health care expenditures in adults
worldwide. The need for improved management of
LBP is intensifying with the growing size of the
adult population, and is exacerbated by the global
epidemic of adult obesity and obesity-related diabe-
tes.1 Overweight and obese conditions are risk
factors for LBP2,3; moreover, diabetes is hypothe-
sized to contribute independently. For example, type
2 diabetes (T2D) appears to increase the frequency
and severity of pain4–7 and is associated with poor
treatment outcomes.8,9 Since LBP is often related to
intervertebral disc degeneration,10 identifying the
mechanisms by which T2D affects disc composition
and biomechanical behavior is an important step
towards improving the management of LBP in
diabetes.
Several mechanisms could link T2D with poor disc
composition and biomechanical behavior. During the
pre-diabetic state, increased insulin levels resulting
from insulin resistance can have an anabolic effect on
bone metabolism.11 Any increase in bone formation in
the endplate (sclerosis) could negatively impact disc
health since the disc is avascular and thus, sclerosis
could hinder the transport of nutrients and metabo-
lites across the endplates to and from the disc.12–14
Hyperglycemia may also be important. Hyperglycemia
is associated with ischemic injury that preferentially
affects organs with non-redundant end capillary circu-
lation.15,16 Accordingly, any injury to the capillary bed
adjacent to the endplate could also contribute to disc
degeneration by reducing the nutrient supply to the
endplate and disc.14
Besides reducing disc nutrient supply, hyperglyce-
mia could impact the disc directly by increasing the
formation of AGEs. AGEs are formed through non-
enzymatic glycation of the free amino groups of
proteins and lipids by reducing sugars.17 In normal
discs, AGE accumulation has been shown to increase
with age,18 trigger catabolic actions within disc cells,19
reduce disc hydration,20 and increase disc tissue
stiffness.21 In diabetes, hyperglycemia accelerates the
ordinarily slow rate of endogenous glycation by in-
creasing the availability of sugars that can attach to
the amino groups.22 Ziv et al. hypothesized that
increased AGE accumulation could underlie the
changes in physiochemical properties observed in the
discs of diabetic sand rats.23 More recently, degenera-
tive changes to the disc, including loss of disc height
and proteoglycans, were associated with AGE accumu-
lation in type 1 diabetic mice.24 In humans, AGEs
appear to be increased and related to catabolic changes
in disc tissues from diabetic patients.25
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Thus, while the links between diabetes and poor
disc health are being uncovered,23–25 supporting data
remain limited. Here, we sought to test the hypothesis
that T2D diminishes disc composition, matrix homeo-
stasis, and biomechanical behavior, and that these
changes are associated with endplate sclerosis, re-
duced endplate vascular supply, and increased AGE
accumulation.
METHODS
Study Design
A critical component of the study design was its ability to
control for the effects of age, disease duration, insulin
resistance, obesity, and glycemic control. Since controlling
for such effects using a statistical analysis of human tissue
obtained during surgery would require a large patient
population, we instead relied on a novel rat model of T2D
that explicitly controls for these factors and thereby makes it
possible to study the effects of diabetes with a much smaller
sample size (n¼ 18 rats total). The University of California
at Davis-type 2 diabetes mellitus (UCD-T2DM) rat was
developed, characterized, and validated to more closely model
the pathophysiology of human T2D than other existing
rodent models.26 By crossing two lines of non-diabetic rats —
one with adult-onset obesity and insulin resistance, without
defects in either leptin production or leptin receptor signal-
ing (obese Sprague-Dawley, OSD) and one with defective
pancreatic beta cell islet function and insulin secretion (ZDF-
lean) — and selectively breeding the offspring to enrich for
diabetes, the subsequent generations demonstrate diabetes
in both sexes with adult-onset obesity, insulin-resistance,
impaired glucose tolerance, and eventual beta cell decompen-
sation. Advantages of this model over other rodent models of
T2D include polygenic rather than monogenic obesity, a later
age of onset, intact leptin signaling, preserved fertility, and
the development of diabetes in both sexes. Here, we com-
pared the UCD-T2DM rats to two non-diabetic control rats:
lean Sprague Dawley (LSD) rats and OSD rats. By compar-
ing UCD-T2DM rats to OSD rats — a genetically similar,
obese and insulin-resistant control — we sought to disentan-
gle the effects of T2D from the effects of obesity, which is
itself an independent risk factor for disc pathology.27
Animals
Coccygeal (CC) spines were harvested from rats following
euthanasia with an overdose of pentobarbital. We focused on
coccygeal discs because they are larger and more readily
accessible than lumbar discs, which facilitates biochemical
and biomechanical analyses. Six-month-old LSD rats (“con-
trol”), OSD rats (“obese”), and UCD-T2DM rats (“diabetic”;
n¼ 6 rats/group) were studied. The generation and pheno-
types of these rats have been previously described.26 Rats
were maintained and studied in accordance with Institutional
Animal Care and Use Committee (IACUC)-approved protocols.
Non-fasted blood glucose was monitored every 2 weeks with a
glucose meter (LifeScan; Milpitas, CA), and the age of diabetes
onset was defined as the age at which hyperglycemia (blood
glucose concentration > 200 mg/dl on two consecutive meas-
urements) was first detected. Blood was collected for measure-
ment of circulating glucose, insulin, and HbA1c after an
overnight fast at the time of killing. Plasma was assayed for
glucose and insulin concentrations with an enzymatic colori-
metric assay (Fisher Diagnostics; Middleton, VA) and electro-
chemiluminescence (Meso Scale Discovery; Rockville, MD),
respectively. HbA1c was measured with an enzymatic colori-
metric assay (Diazyme Laboratories; Poway, CA).
Micro-X-ray Computed Tomography Analysis of Endplate
Microarchitecture (CC4-CC5 Segment)
High-resolution X-ray microscopy was performed to quantify
bony endplate microarchitecture. Microscopy images of the
CC4-CC5 segments were obtained using a Micro-XCT 200
(Xradia Inc.; Pleasanton, CA) with an effective resolution of
5 mm. X-rays were set to a voltage of 50 kVp and a power of
6 W. After image reconstruction, endplate thickness and
porosity were evaluated in cylindrical regions of interest
(1 mm diameter) adjacent to the nucleus pulposus (Fig. 1).28
Measurements derived from endplates cranial and caudal to
the disc were averaged for each motion segment.
Histologic Analysis of Endplate Vascular Supply (CC5-CC6
Segment)
Histology was performed to quantify endplate vascular supply
in the CC5-CC6 segment. Sections were stained with a
solution containing orange G and aniline blue. Images were
evaluated for the area of epiphyseal red blood cells (RBCs)
using the segmentation function in graphics editing software.
The areal fraction of RBCs was defined as the area of RBCs
divided by the total area of the epiphyseal marrow space. This
analysis was performed for three mid-coronal sections per
segment; values from cranial and caudal epiphyses were
averaged for each section and segment. Two raters confirmed
repeatability for 30 sections (r¼ 0.95, p< 0.0001, inter-rater
difference in areal fraction of RBCs¼ 0.06 0.17%).
Biomechanical Assessment of Creep Characteristics (CC6-CC7
Segment)
Compressive creep testing was performed to assess the
viscoelastic characteristics of the discs.29 Briefly, the CC6-
CC7 segments were cleaned of surrounding tissues, radio-
graphed, potted in casting resin, and mounted into an
ElectroForce 3200 load frame (Bose; Eden Prairie, MN). The
loading protocol consisted of five cycles of creep for 20 min at
0.5 MPa followed by recovery for 40 min at 0.1 MPa. Strain-
time data from the final creep cycle were fit to a one-
dimensional fluid transport model30:
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where e(t) is the axial strain, e0 is the strain at t¼ 0, t is the
time, s0 is the applied compressive stress, Posm is the initial
Figure 1. Reconstructed micro-tomography cross-section
(50 mm-thick) illustrating the location of the region of interest for
measurement of endplate thickness and porosity.
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nucleus swelling pressure, hi is the initial disc height, k is
the permeability of the endplate, D is the strain-dependence
of nucleus swelling pressure, and G is the time-dependence
of annulus deformation. Least squares curve fitting was used
to determine k,D and G for a given set of experimental creep
data (MATLAB, The Mathworks Inc.; Natick, MA). Although
not a parameter in the model, an initial modulus of the disc
was calculated by measuring the slope of the stress-strain
curve before the force reached the specified creep load
(0.4 MPa/s ramp rate). All tests were performed in PBS at
room temperature. Initial disc height and cross-sectional
area were estimated from pre-test radiographs.
Biochemical Analysis of GAG Content (CC6-CC7 Segment)
An absorbance assay was used to measure the glycosamino-
glycan (GAG) content in the disc. After biomechanical
testing, nucleus samples from the CC6-CC7 segment were
completely digested in papain solution (20 h, 60˚C). GAG
content was determined using a dimethylmethylene blue
assay.31 GAG content was normalized to the dry mass of the
nucleus pulposus, which we measured following lyophiliza-
tion prior to papain digestion. Water content in the nucleus
pulposus was calculated from the ratio of the tissue mass
measured before and after lyophilization.
Immunoassay of AGE Accumulation (CC9-CC10 and CC10-CC11
Segments)
ELISA was used to measure the concentration of pentosidine
in the disc tissues. Pentosidine is a well-characterized AGE
and inter-molecular cross-link that is a sensitive marker of
non-enzymatic glycation. Samples of annulus (CC9-CC10)
and nucleus (CC10-CC11) were pulverized in a freezer mill
and assayed for pentosidine by sandwich ELISA (MyBio-
Source; San Diego, CA). This ELISA kit has a high sensitivi-
ty (0.02 ng/ml) and precision (CV< 10%). Pentosidine
measurements were normalized to collagen content, which
was calculated from the amount of hydroxyproline.32
PCR Assessment of Matrix Homeostasis (CC8-CC9 Segment)
Quantitative PCR was used to characterize matrix homeosta-
sis. Annulus and nucleus samples (CC8-CC9) were homoge-
nized in Trizol (Sigma; St. Louis, MO), and total RNA was
collected using phenol chloroform and purified with RNeasy
Kits (Qiagen; Valencia, CA). RNA was reverse transcribed
using iScript (Bio-Rad; Hercules, CA), and the resulting
cDNA was pre-amplified and analyzed via quantitative PCR
for the following genes: receptor for AGEs (Rage), vascular
endothelial growth factor alpha (Vegfa), hypoxia-inducible
factor 1-alpha (Hif1a), insulin-like growth factor-1 (Igf1),
insulin receptor (Insr), glucose transporter 1 (Slc2a1), cav-
eolin 1 (Cav1), tumor necrosis factor alpha (Tnfa), twisted
gastrulation protein homolog 1 (Twsg1), tissue inhibitor of
metalloproteinase 1 (Timp1), collagen 2 alpha 1 (Col2a1),
collagen 1 alpha 1 (Col1a1), and aggrecan (Acan). The delta-
delta Ct method was used to calculate relative expression
compared to beta-actin; expression values are reported as
fold change over control.
Statistical Analysis
ANOVA with Tukey-Kramer post-hoc tests was used to
determine the effect of diabetes on the various outcomes.
Despite the small sample size (n¼ 6 rats/group), parametric
tests were used because the data were normally distributed
(p> 0.05, Shapiro–Wilk test). Independent associations be-
tween the outcomes were quantified by the Pearson correla-
tion coefficient. All analyses were performed using JMP 11
(SAS Institute; Cary, NC, USA). Significance is defined by
p< 0.05. Data are given as meanSEM.
RESULTS
Blood glucose measurements indicated that the UCD-
T2DM rats were diabetic for 69 7 diabetic days.
Obese rats and those with diabetes had significantly
higher body weights than age-matched lean controls
(Table 1). At sacrifice, diabetic rats also had substan-
tially higher glucose concentrations and HbA1c.
Diabetes Diminishes Intervertebral Disc GAG and Water
Contents
Despite their normal histologic appearance (Fig. 2),
discs from the diabetic rats demonstrated dramatic
biochemical changes that were consistent with the
early stages of degeneration. Diabetes but not obesity
significantly reduced nucleus GAG content by 51%
(p< 0.005) and water content by 12% (p<0.005).
Radiographic measurements of disc cross-sectional
area indicated that discs from obese rats
(20.2 0.7 mm2) and those with diabetes
(19.8 1.8 mm2) were 34% larger than those from
lean controls (14.81.8 mm2; p¼0.02). The larger
disc size can be appreciated in the histologic sections
(Fig. 2).
Table 1. Body Weight, Glucose, Insulin, and HbA1c Data for Control, Obese, and Diabetic Rats. All Rats Aged 6
Months
Control – Lean
Sprague Dawley
(n¼ 5 rats)
Obese – Obese
Sprague Dawley
(n¼ 6 rats)
Diabetic – UCD-T2DM
(n¼ 6 rats)
Duration of diabetes (days) NA NA 69 7
Body weight (g) 426.0 12.1 693.7 29.0a 563.5 18.9
c,d
Non-fasting glucose (mg/dl) 112.2 3.4 112.2 4.7 546.2 18.5
a,b
Fasting glucose (mg/dl) 91.8 3.2 98.7 2.8 246.4 52.6
c,d
Fasting insulin (ng/ml) 0.6 0.07 1.4 0.2e 1.4 0.3e
HbA1c (%) 4.5 0.09 4.3 0.06 11.8 1.28
a,b
HbA1c (mmol/mol) 26.0 1.0 23.8 0.7 105 14.0
All data given as meanSEM.NA, Not applicable.ap< 0.0001 versus control.bp<0.0001 versus obese.cp<0.05 versus control.dp< 0.05
versus obese.ep< 0.10 versus control.
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Diminished GAG Content Associates with Endplate
Sclerosis and not Reduced Vascular Supply
Diabetes but not obesity caused endplate sclerosis,
with an increase of endplate thickness by 21%
(p<0.05) and a close-to-significant decrease of end-
plate porosity of 41% (p¼0.08; Fig. 3). When the data
were pooled, variations in endplate microarchitecture
were significantly correlated with GAG content. GAG
content decreased with increasing endplate thickness
(r¼ -0.56, p¼0.02) and decreasing endplate porosity
(r¼ 0.47, p¼0.05; Fig. 3). Thicker endplates were less
porous (r¼ -0.61, p¼ 0.008).
The diminished GAG content also suggested a
possible reduction in endplate vascular supply. To
investigate this, the quantity of epiphyseal RBCs was
estimated from histology. Surprisingly, in both obese
non-diabetic and UCD-T2DM diabetic rats, the per-
centage of RBCs in the epiphysis was increased by
87% and 78% (Fig. 4), respectively. This suggests that
endplate vascular supply is unlikely to contribute to
the diminished GAG content observed in the discs
from the diabetic rats.
Diabetes Compromises Disc Biomechanical Behavior
Diabetes caused several deleterious changes to bio-
mechanical properties of the disc that had the net
effect of reducing creep strain (Fig. 5). Diabetes, but
not obesity, nearly doubled the strain dependence of
swelling pressure in the nucleus (p<0.05). Diabetes
also decreased the time dependence of annulus defor-
mation compared with the obese non-diabetic group
(p<0.05). Analysis of disc stress-strain behavior dur-
ing the loading ramp indicated that diabetes increased
the initial modulus (7.5 0.8 MPa) compared with the
obese, non-diabetic rats (3.00.4 MPa, p<0.005) and
lean control rats (3.81.0 MPa, p< 0.01). Endplate
permeability was similar in all groups (p¼ 0.26).
Figure 2. Top: Mid-coronal histology sections of discs from control (left), obese (center), and diabetic rats (right). Heidenhain
connective tissue stain. Bottom: Effect of diabetes and obesity on GAG content (left) and water content (right) in the nucleus pulposus.
MeanSEM for n¼6 rats/group; ap<0.005 versus control, bp<0.005 versus obese.
Figure 3. Top: Diabetes significantly increased endplate thick-
ness (left) and greater thickness correlated with reduced GAG
content (right). Bottom: Diabetes tended to decrease endplate
porosity (left), and reduced porosity correlated with reduced
GAG content (right). MeanSEM for n¼6 rats/group; ap< 0.05
versus control, bp<0.05 versus obese, cp<0.10 versus control.
Scatter plot data are pooled from all groups.
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Diminished Biomechanical Behavior Associated with
Elevated AGE Concentration and Lower GAG Content
Diabetes, but not obesity, significantly increased AGE
concentrations in the disc (Fig. 6). In the annulus,
pentosidine content was elevated by 29% (p<0.01); in
the nucleus, by 104% (p<0.05). When the data were
pooled from all groups, the variation in nuclear
pentosidine content was significantly correlated with
the strain dependence of nucleus swelling pressure
(r¼ 0.49, p¼ 0.04) and with initial modulus (r¼0.57,
p¼ 0.02; Fig. 6).
Biomechanical behavior also showed independent
relationships with water and GAG content. For exam-
ple, lower GAG content was correlated with increased
strain dependence of swelling pressure (r¼ -0.58,
p¼ 0.01) and increased initial modulus (r¼ -0.64,
p¼ 0.004). The finding that biomechanical outcomes
were independently associated with pentosidine and
GAG contents reflects potentially important cross-
correlations between these results, that is, that in-
creased pentosidine content was highly correlated
with lower GAG content (r¼ -0.74, p¼0.002).
Diabetes Compromises Disc Matrix Homeostasis
Diabetes also shifted disc cell metabolism and matrix
homeostasis in a manner that was consistent with
increased AGEs and oxidative stress (Fig. 7). Diabetes
tended to associate with elevated expression of hypox-
ia-sensitive genes, including Vegfa (p<0.10) and
Hif1a (p< 0.10). In the nucleus pulposus, Rage expres-
sion was up-regulated ninefold in the diabetic rats
(additional rats needed to reach significance), which
coincided with their tendency to express lower levels
of Timp1 (p<0.10) and Col2a1 (p<0.05), and with
expressing higher levels of the cytokine Twsg1
(p< 0.05). In the annulus fibrosus, notable findings
included elevated expression of the senescence indica-
tor Cav1 (p<0.05) and of Twsg1 (p<0.05). Relative to
lean controls, diabetic rats also had higher insulin
receptor expression in the nucleus (Insr, p< 0.05) and
annulus (p< 0.10); Igf1 expression tended to be higher
in the annulus (p<0.10). There was no difference in
Acan expression, and reliable amplification data were
not obtained for Tnfa.
DISCUSSION
We report that diabetes significantly undermines disc
GAG and water contents, matrix homeostasis, and
biomechanical behavior in a rat model of T2D. Most
notably, diabetes was associated with a 50% reduction
in the GAG content of the disc nucleus and a 12%
reduction in disc hydration. For comparison, the
magnitude of these differences is comparable to those
observed between non-degenerate (Pfirrmann grade
Figure 4. Photomicrograph showing the epiphyseal bone marrow cavity from a diabetic rat (left). Custom stain: RBCs are stained
orange; vessel walls and bone matrix are stained blue. Diabetes and obesity significantly increased the percentage of the epiphyseal
marrow space occupied by RBCs (center). In absolute terms, diabetes and obesity tended to double the area of RBCs (right; values
normalized to the ‘control’ group). MeanSEM for n¼4–7 rats/group; ap<0.05 versus control; cp<0.10 versus control.
Figure 5. Effect of diabetes and obesity on disc creep properties. Creep behavior (right) showed that discs from the diabetic rats
compressed less under the constant applied stress, indicating they were stiffer. MeanSEM for n¼5–6 rats/group; ap<0.05 versus
control, bp< 0.05 versus obese.
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1.9) and moderately degenerate (Pfirrmann grade 3.6)
human lumbar discs.33 Moreover, the diminished GAG
and water contents in the diabetic rats coincided with
impairments in structural characteristics of the end-
plate that could reduce nutrient transport and with
cellular indicators of increased oxidative stress and
AGE/RAGE-mediated biological interactions. For ex-
ample, besides increasing endplate thickness 21% and
decreasing endplate porosity 40%, diabetes increased
expression of hypoxia-induced genes (Vegfa, Hif1a)
and decreased expression of markers of matrix health
(Timp1, Col2a1). Diabetes also had negative bio-
mechanical consequences: disc stiffness was increased
by 97%, which was correlated with lower GAG content
and with elevated levels of the AGE pentosidine.
Previous studies suggest a link between diabetes and
intervertebral disc degeneration,23 and AGE accumu-
lation is believed to be important.20,24,25 Our results
extend those prior findings by demonstrating that
endplate sclerosis, increased oxidative stress, and
AGE/RAGE-mediated interactions are consequences of
T2D that are linked to detrimental changes in the
GAG and water content, matrix homeostasis and
biomechanical function of the intervertebral disc.
One novel aspect of this study is the use of creep
testing for determination of the biomechanical effects
of diabetes. Our findings indicate that diabetes signifi-
cantly reduces disc creep strain and increases disc
stiffness, changes that are correlated with increased
pentosidine content. This study is the first to demon-
strate that diminished biomechanical behavior with
diabetes is associated with elevated AGE concentra-
tions. While we are unaware of other studies that
assessed disc biomechanical behavior and AGEs in
Figure 6. Diabetes but not obesity significantly increased pentosidine content in the annulus fibrosus and nucleus pulposus, and
greater nucleus pentosidine content correlated with greater strain dependence of swelling pressure and initial modulus. MeanSEM
for n¼ 6 rats/group; ap<0.01 versus control, bp<0.05 versus obese. Scatter plot data are pooled from all groups.
Figure 7. Effect of diabetes and obesity on disc
gene expression (fold changes relative to control
rats). MeanSEM for n¼ 5–6 rats/group; letters
indicate significant and trending differences with
greater than twofold change; ap<0.05 versus
control, bp<0.05 versus obese, cp<0.10 versus
control, dp< 0.10 versus obese.
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T2D, our findings are consistent with observations from
a study of healthy annulus fibrosus tissue, which
showed that glycation increases tissue stiffness in a
manner consistent with structural cross-linking.21 We
also found that increased disc stiffness correlated with
reduced water content. Disc water content relates to
swelling pressure, which is a balance between fixed
charge density and tissue stiffness. Importantly, AGEs
appear to affect both characteristics. Besides lowering
the hydrophilic charge of the GAGs,20 increases in
AGEs and one of their receptors Rage could elevate the
level of reactive oxygen species34,35 and induce inflam-
matory changes that also increase tissue stiffness by
promoting matrix catabolism.24,36,37 For example,
Illien-Junger et al. demonstrated that this AGE-associ-
ated catabolic response is implicated in the develop-
ment of spinal pathology in type 1 diabetic mice.24
Here, we found that Rage expression was higher in the
nucleus pulposus of the diabetic rats, which coincided
with lower Timp1 and Col2a1 expression. Taken
together, these findings suggest that the dramatic
alterations in disc biomechanical behavior with T2D
relate to the structural and biological effects of AGEs.
Another novel aspect of this study was the quantifi-
cation of endplate microarchitecture in diabetic ani-
mals. We found T2D caused endplate sclerosis,
increasing endplate thickness, and decreasing end-
plate porosity, and that sclerosis correlated with
diminished disc GAG content. This study is the first to
report that disc degenerative changes occurring with
T2D are associated with endplate sclerosis. Although
we are unaware of any studies in humans or animals
reporting on sclerosis-GAG content relationships in
diabetes, similar relationships were reported in discs
from non-diabetic humans12,28 and rats,13 supporting
the generality of our findings. Benneker et al. studied
discs from donors aged 19–86 years and found that
endplate pore density was significantly correlated with
adjacent nucleus GAG content.12 More recently, we
reported that donors with thinner and more porous
double-layer endplates had higher adjacent GAG/cell
when compared with donors that had single-layer
endplates.28 In aging sand rats, Gruber et al. reported
that increased endplate bone mineral density was
correlated with reduced annulus cell viability.13 Given
the consistency of our findings with these prior
studies, the collective literature suggests that endplate
sclerosis with T2D may be an important factor that
contributes to poor disc health.
Disc health also depends on capillaries that supply
nutrients to the endplate-disc interface. An unexpect-
ed finding was that both obese rats and those with
T2D have increased RBC density compared with the
lean controls. This appears to be inconsistent with the
finding that diabetes decreased GAG content, yet
obesity alone had no appreciable effect. However,
Boubriak et al. reported that endplate capillary size
and density is increased with disc size.14 In the
current study, obese and diabetic rats had 34% greater
disc cross-sectional areas, which could explain their
greater RBC density. Hence, the diverging GAG
contents in those groups is not inconsistent with the
increased RBC density; rather, taken together with
the effect of diabetes, but not obesity on endplate
microarchitecture, these findings further underscore
the possible role of endplate sclerosis in contributing
to compromised GAG content and matrix homeostasis
in T2D.
Despite its potential importance, the cause of
endplate sclerosis in the diabetic rats is unknown. One
possible explanation relates to the anabolic effects of
insulin on bone metabolism. Insulin stimulates osteo-
blast activity,38 and accordingly, hyperinsulinemia is
associated with increased bone mineral density in
humans39 and rodents.11 Here, insulin levels were
similar in the obese non-diabetic and diabetic rats
(1.40.3 ng/ml), although the diabetic rats have great-
er than twofold higher insulin levels at diabetes onset
(3.40.3 ng/ml),26 which may have contributed to
sclerotic endplate changes that persisted following the
decline in insulin levels thereafter. Additional factors
that could explain the observed endplate sclerosis
include the possible remodeling response to AGE-
associated bone fragility40 and/or the osteogenic effects
of increased RAGE signaling in chondrocyte-like
cells.41,42
This study has a number of limitations. Most
importantly, we did not study animals with an
advanced duration and severity of diabetes, which
may limit the generality of the conclusions. However,
since diminished GAG content and biomechanical
behavior was associated with increased pentosidine
content, and because pentosidine content increases
with diabetes duration and severity,43 GAG content
and biomechanical behavior would both be expected to
progressively worsen with a longer duration of diabe-
tes and greater degree of hyperglycemia. This is
consistent with findings in bones from hyperglycemic
WBN/Kob rats, where AGE-related biomechanical def-
icits increased with disease duration.44 A second
limitation is that renal failure could contribute inde-
pendently to the increased AGE accumulation in the
diabetic rats. However, while the UCD-T2DM rats
show progressive renal dysfunction, it is far from end-
stage in the young rats that we studied (data not
shown). Thus, any contribution of renal dysfunction to
AGE accumulation in our study is likely to be second-
ary compared to the effects of hyperglycemia and
oxidative stress. A third limitation is that we focused
on non-enzymatic cross-links rather than on enzymatic
cross-links, which have a stabilizing effect on the
collagen network and could also be increased by
diabetes. Yet data from other rat models of diabetes
indicate that changes in enzymatic cross-links are
minor compared to the large increases in non-enzy-
matic cross-links,44,45 which suggests that measuring
enzymatic cross-links would not have altered our
conclusions. Finally, analysis of additional rats is
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needed to confirm some of the gene expression trends.
We expect that studying additional rats would not
alter the effect size but would instead reduce the
reported variances.
In summary, our results show that T2D compro-
mises disc GAG and water contents, matrix homeosta-
sis and biomechanical behavior, and these changes are
associated with endplate sclerosis and AGE accumula-
tion. Endplate sclerosis, increased oxidative stress,
and AGE/RAGE-mediated interactions in the disc
could therefore be important factors contributing to
the increased incidence of disc pathology in T2D.
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